Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2017, Article ID 1589356, 5 pages
https://doi.org/10.1155/2017/1589356
Case Report

Leflunomide in the Treatment of a Pseudotumoral Genital Herpes Simplex Virus Infection in an HIV Patient

1IDT Clinic, 1905 Clint Moore Rd, Suite 305, Boca Raton, FL 33496, USA
2Department of Medicine, Division of Infectious Diseases, South Texas Veterans Healthcare System, 7400 Merton Minter Blvd, San Antonio, TX 78229, USA
3Department of Medicine, Division of Infectious Diseases, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA

Correspondence should be addressed to Gregory M. Anstead; ude.ascshtu@daetsna

Received 16 November 2016; Revised 18 January 2017; Accepted 31 January 2017; Published 8 March 2017

Academic Editor: Sinésio Talhari

Copyright © 2017 Marie R. Roger and Gregory M. Anstead. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Ranu, J. Lee, M. Chio, and P. Sen, “Tumour-like presentations of anogenital herpes simplex in HIV-positive patients,” International Journal of STD and AIDS, vol. 22, no. 4, pp. 181–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. D. Strehl, G. Mehlhorn, M. C. Koch et al., “HIV-associated hypertrophic herpes simplex genitalis with concomitant early invasive squamous cell carcinoma mimicking advanced genital cancer: case report and literature review,” International Journal of Gynecological Pathology, vol. 31, no. 3, pp. 286–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Sbidian, M. Battistella, J. LeGoff et al., “Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy,” Clinical Infectious Diseases, vol. 57, no. 11, pp. 1648–1655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Mosunjac, J. Park, W. Wang et al., “Genital and perianal herpes simplex simulating neoplasia in patients with AIDS,” AIDS Patient Care and STDs, vol. 23, no. 3, pp. 153–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Cury, N. Valin, J. Gozlan et al., “Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient,” Sexually Transmitted Diseases, vol. 37, no. 2, pp. 126–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Deza, G. Martin-Ezquerra, L. Curto-Barredo, J. Villar García, and R. M. Pujol, “Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod,” Journal of Dermatology, vol. 42, no. 12, pp. 1176–1178, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. F. Henao-Martínez, A. Weinberg, W. J. Waldman, and M. E. Levi, “Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man,” Journal of Clinical Virology, vol. 54, no. 3, pp. 276–278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Armbruster and M. Drlicek, “Herpes simplex virus type II infection as an exophytic endobronchial tumor,” Wiener Klinische Wochenschrift, vol. 107, no. 11, pp. 344–346, 1995. View at Google Scholar · View at Scopus
  9. A. Upadya, L. Tilluckdharry, C. D. Nagy, P. Ravichandran, and C. Manthous, “Endobronchial pseudo-tumour caused by herpes simplex,” European Respiratory Journal, vol. 25, no. 6, pp. 1117–1120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Katsenos, D. Sampaziotis, and S. Archondakis, “Tracheal pseudo-tumor caused by herpes simplex virus,” Multidisciplinary Respiratory Medicine, vol. 8, article no. 42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Celgene Corp, Thalidomid, “Highlights of prescribing information”, 1998–2015, http://www.thalomid.com/wp-content/uploads/thalomid-prescribing-information.pdf.
  12. C. Leeyaphan, T. M. Surawan, P. Chirachanakul et al., “Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study,” International Journal of Infectious Diseases, vol. 33, pp. e165–e170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. K. Sall, C. L. Kauffman, and C. S. Levy, “Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome,” Archives of Dermatology, vol. 125, no. 11, pp. 1548–1550, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. H. H. Balfour, C. Benson, J. Braun et al., “Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections,” Journal of Acquired Immune Deficiency Syndromes, vol. 7, no. 3, pp. 254–260, 1994. View at Google Scholar · View at Scopus
  15. W. J. Waldman, D. A. Knight, N. S. Lurain et al., “Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide,” Transplantation, vol. 68, no. 6, pp. 814–825, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. R. K. Avery, B. J. Bolwell, B. Yen-Lieberman et al., “Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection,” Bone Marrow Transplantation, vol. 34, no. 12, pp. 1071–1075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Morita, K. Shinoda, S. Tamaki et al., “Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: a case report and literature review,” Journal of Clinical Virology, vol. 82, pp. 133–138, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Knight, A. Q. Hejmanowski, J. E. Dierksheide, J. W. Williams, A. S.-F. Chong, and W. J. Waldman, “Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide,” Transplantation, vol. 71, no. 1, pp. 170–174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. W. Williams, D. Mital, A. Chong et al., “Experiences with leflunomide in solid organ transplantation,” Transplantation, vol. 73, no. 3, pp. 358–366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Chong, H. Zeng, D. A. Knight et al., “Concurrent antiviral and immunosuppressive activities of leflunomide in vivo,” American Journal of Transplantation, vol. 6, no. 1, pp. 69–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. I. Fox, M. L. Herrmann, C. G. Frangou et al., “Mechanism of action for leflunomide in rheumatoid arthritis,” Clinical Immunology, vol. 93, no. 3, pp. 198–208, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Bhattarakosol, S. Visaprom, A. Sangdara, and V. Mungmee, “Increase of genital HSV-1 and mixed HSV-1 and HSV-2 infection in Bangkok, Thailand,” Journal of the Medical Association of Thailand, vol. 88, S4, pp. S300–304, 2005. View at Google Scholar · View at Scopus
  23. H. Kaneko, T. Kawana, K. Ishioka, S. Ohno, K. Aoki, and T. Suzutani, “Evaluation of mixed infection cases with both herpes simplex virus types 1 and 2,” Journal of Medical Virology, vol. 80, no. 5, pp. 883–887, 2008. View at Publisher · View at Google Scholar · View at Scopus